UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Drug discovery in pharmaceutical industry: productivity challenges and trends

Drug discovery today, 2012-10, Vol.17 (19-20), p.1088-1102

Khanna, Ish

2012

Volltextzugriff (PDF)

Buprenorphine - an attractive opioid with underutilized potential in treatment of chronic pain

Journal of Pain Research, 2015-01, Vol.8 (Issue 1), p.859-870

2015

Volltextzugriff (PDF)

A multimodal disease modifying approach to treat neuropathic pain – inhibition of soluble epoxide hydrolase (sEH)

Drug discovery today, 2015-11, Vol.20 (11), p.1382-1390

2015

Volltextzugriff (PDF)

Fatty acid amide hydrolase inhibitors--progress and potential

CNS & neurological disorders drug targets, 2011-08, Vol.10 (5), p.545-558

2011

Volltextzugriff (PDF)

Targeting Soluble Epoxide Hydrolase for Inflammation and Pain - An Overview of Pharmacology and the Inhibitors

Inflammation & allergy drug targets, 2012-04, Vol.11 (2), p.143-158

2012

Volltextzugriff (PDF)

An AMPK activator as a therapeutic option for congenital nephrogenic diabetes insipidus

JCI insight, 2021-04, Vol.6 (8)

2021

Volltextzugriff (PDF)

Design and optimization of quinazoline derivatives as melanin concentrating hormone receptor 1 (MCHR1) antagonists

Bioorganic & medicinal chemistry letters, 2012-05, Vol.22 (9), p.3157-3162

2012

Volltextzugriff (PDF)

Design and optimization of quinazoline derivatives as melanin concentrating hormone receptor 1 (MCHR1) antagonists: Part 2

Bioorganic & medicinal chemistry letters, 2012-05, Vol.22 (9), p.3163-3167

2012

Volltextzugriff (PDF)

A multimodal disease modifying approach to treat neuropathic pain - inhibition of soluble epoxide hydrolase (sEH): Post screen

Drug discovery today, 2015-11, Vol.20 (11), p.1382-1390

2015

Volltextzugriff (PDF)

1,2-Diarylimidazoles as Potent, Cyclooxygenase-2 Selective, and Orally Active Antiinflammatory Agents

Journal of medicinal chemistry, 1997-05, Vol.40 (11), p.1634-1647

1997

Volltextzugriff (PDF)

1,2-Diarylpyrroles as Potent and Selective Inhibitors of Cyclooxygenase-2

Journal of medicinal chemistry, 1997-05, Vol.40 (11), p.1619-1633

1997

Volltextzugriff (PDF)

Discovery of + (2 -{4 -[2 -(5,6,7,8 -tetrahydro -1,8 -naphthyridin -2-yl )ethoxy ]phenyl} -cyclopropyl )acetic acid as potent and selective αvβ3 inhibitor : Design, synthesis, and optimization

Bioorganic & medicinal chemistry, 2007-05, Vol.15 (10), p.3390-3412

2007

Volltextzugriff (PDF)

Pain and beyond: fatty acid amides and fatty acid amide hydrolase inhibitors in cardiovascular and metabolic diseases

Drug discovery today, 2009-12, Vol.14 (23-24), p.1098-1111

2009

Volltextzugriff (PDF)

Targeting soluble epoxide hydrolase for inflammation and pain - an overview of pharmacology and the inhibitors

Inflammation & allergy drug targets, 2012-04, Vol.11 (2), p.143

2012

Volltextzugriff (PDF)

Facile, Regioselective Syntheses of N-Alkylated 2,3-Diaminopyridines and Imidazo[4,5-b]pyridines

Journal of organic chemistry, 1995-02, Vol.60 (4), p.960-965

1995

Volltextzugriff (PDF)

Optimisation of in silico derived 2-aminobenzimidazole hits as unprecedented selective kappa opioid receptor agonists

Bioorganic & medicinal chemistry letters, 2015-02, Vol.25 (4), p.887-892

2015

Volltextzugriff (PDF)

Discovery of novel, orally available benzimidazoles as melanin concentrating hormone receptor 1 (MCHR1) antagonists

Bioorganic & medicinal chemistry letters, 2010-09, Vol.20 (18), p.5443-5448

2010

Volltextzugriff (PDF)

Selective Cyclooxygenase-2 Inhibitors: Heteroaryl Modified 1,2-Diarylimidazoles Are Potent, Orally Active Antiinflammatory Agents

Journal of medicinal chemistry, 2000-08, Vol.43 (16), p.3168-3185

2000

Volltextzugriff (PDF)

Synthesis and SAR studies of benzimidazole derivatives as melanin concentrating hormone receptor 1 (MCHR1) antagonists: Focus to detune hERG inhibition

MedChemComm, 2011-05, Vol.2 (5), p.385

2011

Volltextzugriff (PDF)

Chapter 12 Recent Trends in HDL Modulating Therapies

Annual Reports in Medicinal Chemistry, 2007, Vol.42, p.177-191

2007

Volltextzugriff (PDF)

Antimicrobial agents from higher plants: Prenylated flavonoids and other phenols from Glycyrrhiza lepidota

Phytochemistry (Oxford), 1983, Vol.22 (2), p.573-576

1983

Volltextzugriff (PDF)

Discovery of +(2-{4-[2-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)ethoxy]phenyl}-cyclopropyl)acetic acid as potent and selective alphavbeta3 inhibitor: design, synthesis, and optimization

Bioorganic & medicinal chemistry, 2007-05, Vol.15 (10), p.3390-3412

2007

Volltextzugriff (PDF)

1 – 25 von 42

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(41)
Mit Volltextzugriff
(38)

Publikationsform

Artikel
(40)
Buchkapitel
(2)

Sprache

Englisch
(42)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Drug discovery in pharmaceutical industry: productivity challenges and trends

Buprenorphine - an attractive opioid with underutilized potential in treatment of chronic pain

A multimodal disease modifying approach to treat neuropathic pain – inhibition of soluble epoxide hydrolase (sEH)

Fatty acid amide hydrolase inhibitors--progress and potential

Targeting Soluble Epoxide Hydrolase for Inflammation and Pain - An Overview of Pharmacology and the Inhibitors

An AMPK activator as a therapeutic option for congenital nephrogenic diabetes insipidus

Design and optimization of quinazoline derivatives as melanin concentrating hormone receptor 1 (MCHR1) antagonists

Design and optimization of quinazoline derivatives as melanin concentrating hormone receptor 1 (MCHR1) antagonists: Part 2

A multimodal disease modifying approach to treat neuropathic pain - inhibition of soluble epoxide hydrolase (sEH): Post screen

1,2-Diarylimidazoles as Potent, Cyclooxygenase-2 Selective, and Orally Active Antiinflammatory Agents

1,2-Diarylpyrroles as Potent and Selective Inhibitors of Cyclooxygenase-2

Convergent, parallel synthesis of a series of β-substituted 1,2,4-oxadiazole butanoic acids as potent and selective αvβ3 receptor antagonists

Discovery of + (2 -{4 -[2 -(5,6,7,8 -tetrahydro -1,8 -naphthyridin -2-yl )ethoxy ]phenyl} -cyclopropyl )acetic acid as potent and selective αvβ3 inhibitor : Design, synthesis, and optimization

Pain and beyond: fatty acid amides and fatty acid amide hydrolase inhibitors in cardiovascular and metabolic diseases

Targeting soluble epoxide hydrolase for inflammation and pain - an overview of pharmacology and the inhibitors

Facile, Regioselective Syntheses of N-Alkylated 2,3-Diaminopyridines and Imidazo[4,5-b]pyridines

Optimisation of in silico derived 2-aminobenzimidazole hits as unprecedented selective kappa opioid receptor agonists

Discovery of novel, orally available benzimidazoles as melanin concentrating hormone receptor 1 (MCHR1) antagonists

Selective Cyclooxygenase-2 Inhibitors: Heteroaryl Modified 1,2-Diarylimidazoles Are Potent, Orally Active Antiinflammatory Agents

Synthesis and SAR studies of benzimidazole derivatives as melanin concentrating hormone receptor 1 (MCHR1) antagonists: Focus to detune hERG inhibition

Chapter 12 Recent Trends in HDL Modulating Therapies

Antimicrobial agents from higher plants: Prenylated flavonoids and other phenols from Glycyrrhiza lepidota

Discovery of +(2-{4-[2-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)ethoxy]phenyl}-cyclopropyl)acetic acid as potent and selective alphavbeta3 inhibitor: design, synthesis, and optimization

Discovery of +(2-{4-[2-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)ethoxy]phenyl}-cyclopropyl)acetic acid as potent and selective α vβ 3 inhibitor: Design, synthesis, and optimization

Convergent, parallel synthesis of a series of beta-substituted 1,2,4-oxadiazole butanoic acids as potent and selective alpha(v)beta3 receptor antagonists

Suchergebnisse filtern